← FDA DRUG APPROVALS

FDA ANDA · ANDA076301

LORATADINE ANTIHISTAMINE

loratadine

Sponsor: PERRIGO

APPLICATION
ANDA076301
TYPE
ANDA
ORIGINAL APPROVAL
2004-06-25
LATEST ACTION
2011-09-23
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Over-the-counter

Products

LORATADINEOver-the-counter
LORATADINE 10MG · TABLET · ORAL

Approval history

2011-09-23Labeling · Supplement 25AP
2009-03-20Labeling · Supplement 21AP
2004-06-25OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →